Skip Nav Destination
Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury
Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution
Issue Archive
July 8 2025
In Progress
Volume 9 Issue 13 | Blood Advances | American Society of Hematology
CLINICAL TRIALS AND OBSERVATIONS
Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury
Clinical Trials & Observations
E. Bridget Kim,Jack E. Malespini,Matthew Lei,Samuel S. Han,Cole W. Minsky,Andrew R. Branagan,Elizabeth K. O’Donnell,Diana Cirstea,Noopur S. Raje,Andrew J. Yee
Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution
Clinical Trials & Observations
Andreas Riedel,Laurent Phely,Stefan Hug,Philipp Faustmann,Jan Christian Schroeder,Britta Besemer,Anna M. Paczulla Stanger,Christoph Faul,Claudia Lengerke,Jan Frederic Weller,Wolfgang Bethge
THROMBOSIS AND HEMOSTASIS
Red Cells, Iron, and Erythropoiesis
Lymphoid Neoplasia
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era
Pontus Hedberg,Lisa Blixt,Sandra Eketorp Sylvan,Isabela Killander Möller,Hannes Lindahl,Fredrik Kahn,Åsa Nilsdotter-Augustinsson,Mats Fredrikson,Sofia Nyström,Peter Bergman,Christina Carlander,Soo Aleman,Pontus Nauclér,Anders Österborg,Lotta Hansson
COMMENTARY
MYELOID NEOPLASIA
Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction
Meira Yisraeli Salman,Alexander R. Terry,Andriy Derkach,David Nemirovsky,Kuo-Kai Chin,Yannis K. Valtis,Leora Boussi,Theresa Spivey,Wenbin Xiao,Christopher Famulare,Jenna Ciervo,Jacob M. Rowe,Martin S. Tallman,Eytan M. Stein
Inside Blood Advances
Advertisement intended for health care professionals
Advertisement intended for health care professionals
COVID-19 and CLL in Sweden: lessons learned?